The Chemotherapy-Induced Nausea and Vomiting (CINV) Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?
The Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market has witnessed substantial growth in recent times. The market is projected to rise from $2.92 billion in 2024 to $3.15 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Chemotherapy-Induced Nausea and Vomiting (CINV) Industry?
The global market for chemotherapy-induced nausea and vomiting (CINV) is projected to grow to $4.2 billion by 2029, with a compound annual growth rate (CAGR) of 7.5%.
Download Your Free Sample of the 2025 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?
The key drivers in the chemotherapy-induced nausea and vomiting (cinv) market are:
• Development and progression of personalized medicine
• Advancements made in antiemetic agents
• The rise of telehealth and remote monitoring capabilities
• Implementation of health equity initiatives
Global Market Segmentation: Identifying Major Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Segments
The chemotherapy-induced nausea and vomiting (CINV) market covered in this report is segmented –
1) By Form: Injectables, Oral, Transdermal Patches
2) By Drug Class: 5-HT3 Receptor Antagonists, Neurokinin-1 Receptor Antagonists, Corticosteroids, Cannabinoids, Other Drug Class
3) By Emetogenic Risk: Highly Emetogenic Chemotherapy (HEC), Moderately Emetogenic Chemotherapy (MEC), Low Emetogenic Chemotherapy (LEC)
4) By Distribution Channel: CINV Hospitals, Cancer Research Institute, Retail Pharmacies, Online Pharmacies, Drug Stores
5) By Application: Gynecology, Urology, Gastrointestinal Surgery, Other Applications
Pre-order the 2025 Chemotherapy-Induced Nausea and Vomiting (CINV) Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?
The key trends in the chemotherapy-induced nausea and vomiting (cinv) market are:
• A move towards personalized medicine is a notable emerging trend.
• The development and advancement of antiemetic agents are influencing the future market.
• Telehealth and remote monitoring as management tools are becoming increasingly popular.
• Health equity initiatives, combination antiemetic therapies, supportive care services, and digital health tools are key trends shaping the future market.
Who Are the Top Competitors & Leading Players in the Chemotherapy-Induced Nausea and Vomiting (CINV) Market?
Major companies in the chemotherapy-induced nausea and vomiting (cinv) market are:
• Pfizer Inc.
• Roche Holding AG
• Merck & Co. Inc.
• AbbVie Inc.
• Novartis AG
• AstraZeneca PLC
• GlaxoSmithKline PLC
• Baxter International Inc.
• Teva Pharmaceuticals Industries Ltd.
• Bausch Health Companies Inc.
• Eisai Co. Ltd.
• Jazz Pharmaceuticals PLC
• Ono Pharmaceutical Co. Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Kyowa Kirin Inc.
• Amneal Pharmaceuticals Inc.
• Mundipharma International Limited
• Insys Therapeutics Inc.
• Lupin Limited
• Helsinn Holding S.A.
• Heron Therapeutics Inc.
• Camurus AB
• Cadila Pharmaceuticals Limited
• Acacia Pharma Ltd.
• Soligenix Inc.
Regional Dominance: Which Area Leads the Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market?
North America was the largest region in the chemotherapy-induced nausea and vomiting (CINV) market in 2024
